Matthieu Masureel

Matthieu Masureel

Company: Genentech

Job title: Senior Scientist, Structural Biology

Seminars:

Panel Discussion: Which Modality to Choose? Debating the Implementation of Biologics vs Small Molecules 4:45 pm

With only 3 FDA approved antibodies and roughly 20 in development, what are the hurdles to showing efficacy in antibody drug development for GPCRs Will antibodies replace small molecules in the GPCR space? Are there indications where an antibody may fair better or equal to small molecules (oncology space?)Read more

day: Day One

Structural Insights into Antibody-Based Targeting of a Family A GPCR 2:15 pm

Cryo-EM structure of a family A GPCR in complex with an extracellular antibody Structural insights into a GPCR of therapeutic interest Insights into antibodies as a GPCR structural chaperone and targeting modalityRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.